We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.75T
| $470M | 2.89% |
+15,110,160
| New | +$456M |
|
|
2
Intel
INTC
$499B
| $380M | 2.34% |
12,163,192
+8,608,452
| +242% | +$290M |
|
|
3
Union Pacific
UNP
$181B
| $328M | 2.02% |
3,031,433
+1,351,285
| +80% | +$159M |
|
4
Comcast
CMCSA
$76.9B
| $309M | 1.9% |
10,927,660
+3,287,402
| +43% | +$94.5M |
|
5
Qualcomm
QCOM
$178B
| $301M | 1.85% |
4,336,196
+626,549
| +17% | +$44.2M |
|
6
Nokia
NOK
$53.6B
| $284M | 1.75% |
37,529,006
+1,480,015
| +4% | +$11.5M |
|
|
TWC
7
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $252M | 1.55% |
1,682,954
+420,046
| +33% | +$62.6M |
|
8
Citigroup
C
$222B
| $245M | 1.51% |
4,763,979
-1,251,311
| -21% | -$63.7M |
|
9
ASML
ASML
$685B
| $222M | 1.37% |
2,201,198
+1,031,137
| +88% | +$108M |
|
10
American International
AIG
$41.5B
| $213M | 1.31% |
3,891,408
+830,420
| +27% | +$44.5M |
|
11
Micron Technology
MU
$1.08T
| $208M | 1.28% |
7,682,043
+1,615,952
| +27% | +$48.3M |
|
|
NVO
12
Novo Nordisk
NVO
$217B
| $186M | 1.15% |
6,974,122
-4,931,578
| -41% | -$114M |
|
13
Bank of America
BAC
$430B
| $184M | 1.13% |
11,924,353
+1,348,782
| +13% | +$21.7M |
|
14
Ericsson
ERIC
$30.8B
| $183M | 1.12% |
14,552,816
+3,286,084
| +29% | +$41.1M |
|
|
15
Philip Morris
PM
$301B
| $182M | 1.12% |
2,421,998
+1,601,744
| +195% | +$130M |
|
16
HP
HPQ
$22.9B
| $174M | 1.07% |
12,329,533
+1,061,646
| +9% | +$17.5M |
|
17
CVS Health
CVS
$137B
| $174M | 1.07% |
1,690,007
+595,769
| +54% | +$60.3M |
|
18
HCA Healthcare
HCA
$85.8B
| $160M | 0.98% |
2,123,200
-1,686,590
| -44% | -$121M |
|
19
Magna International
MGA
$18.1B
| $147M | 0.91% |
2,755,404
+688,990
| +33% | +$35.5M |
|
|
20
Canadian National Railway
CNI
$79.7B
| $146M | 0.9% |
2,183,157
-2,594,977
| -54% | -$177M |
|
|
SHPG
21
DELISTED
Shire pic
SHPG
| $142M | 0.88% |
595,049
-689,337
| -54% | -$158M |
|
22
Lincoln National
LNC
$7.78B
| $140M | 0.86% |
2,440,861
+265,008
| +12% | +$14.8M |
|
|
23
AT&T
T
$159B
| $139M | 0.86% |
+5,641,097
| New | +$143M |
|
24
IBM
IBM
$197B
| $134M | 0.83% |
874,397
+805,151
| +1,163% | +$122M |
|
25
General Motors
GM
$72.9B
| $131M | 0.81% |
3,497,408
+1,413,953
| +68% | +$51.4M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.